Kolexia
Boualit Medina Gastro-entérologie
Boualit Medina
Gastro-entérologie
Polyclinique Vauban
Valenciennes, France
41 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie de Crohn Maladies inflammatoires intestinales Colite Rectocolite hémorragique Sténose pathologique Complications postopératoires Malformations Naissance prématurée Gastrite

Collaborateurs

Voir plus
Nachury Maria
Nachury Maria
Hôpital Huriez, Lille, France
Painchart Claire
Painchart Claire
Centre Hospitalier de Denain, Denain, France
Boruchowicz Arnaud
Boruchowicz Arnaud
Centre Hospitalier de Valenciennes, Valenciennes, France
Marks-Brunel Anne-Bérangère
Marks-Brunel Anne-Bérangère
Polyclinique Vauban, Valenciennes, France

Industries

Voir plus
Janssen
34 collaboration(s)
Dernière en 2023
Abbvie
19 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
14 collaboration(s)
Dernière en 2023
Fresenius Kabi
7 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
DOP89 Impact of biologics on the risk of early postoperative complications in Crohn’s disease: a French nationwide study
Abstracts of the 18th Congress of ECCO Copenhagen, Denmark, March 1-4, 2023   30 janvier 2023
The IBD-disk Is a Reliable Tool to Assess the Daily-life Burden of Patients with Inflammatory Bowel Disease.
Journal of Crohn's & colitis   16 novembre 2021
Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study.
Alimentary pharmacology & therapeutics   07 décembre 2020
Long-term outcome of Crohn's disease patients with upper gastrointestinal stricture: A GETAID study.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   20 septembre 2020
P447 No severe neonatal and maternal complications in inflammatory bowel diseases patients treated with ustekinumab or vedolizumab during pregnancy
Abstracts of the 15th Congress of ECCO Vienna, Austria, February 12–15, 2020   15 janvier 2020
Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort study.
Journal of Crohn's & colitis   20 novembre 2019
Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn's Disease.
Digestive diseases and sciences   10 octobre 2019
Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab.
Inflammatory bowel diseases   31 mai 2018
Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988-2011): A Population-Based Study of French Adolescents.
The American journal of gastroenterology   15 août 2017
Adalimumab dose escalation is effective and well tolerated in Crohn's disease patients with secondary loss of response to adalimumab.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   14 novembre 2016